Benefits of Human Genome Project

Rapid progress in genome science and a glimpse intobreast cancer. This will provoke a new era of
its potential applications have spurred observers tomolecular medicine characterized less by treating
predict that biology will be the foremost science ofsymptoms and more by looking to the most
the 21st century. Technology and resourcesfundamental causes of disease. Rapid and more
generated by the Human Genome Project and otherspecific diagnostic tests will make possible earlier
genomics research are already having a major impacttreatment of countless maladies. Medical researchers
on research across the life sciences. The potential foralso will be able to devise novel therapeutic regimens
commercial development of genomics researchbased on new classes of drugs, immunotherapy
presents U.S. industry with a wealth of opportunities,techniques, avoidance of environmental conditions
and sales of DNA-based products and technologies inthat may trigger disease, and possible augmentation
the biotechnology industry are projected to exceedor even replacement of defective genes through
$45 billion by 2009 (Consulting Resources Corporationgene therapy. Besides, research on human evolution
Newsletter, Spring 1999).become easier and clearer when a full and detailed
Some current and potential applications of genomegenome map have been created.
research include molecular medicine, microbialUnderstanding the human genome will have an
genomics, risk assessment, bioarchaeology,enormous impact on the ability to assess risks posed
anthropology, evolution, human migration, DNAto individuals by exposure to toxic agents. Scientists
forensics (identification), agriculture, livestockknow that genetic differences make some people
breeding, and bioprocessing.more susceptible and others more resistant to such
Technology and resources promoted by the Humanagents. Human Genome Project technologies also can
Genome Project have profound impacts onhelp to assess health damage and risks caused by
biomedical research especially in clinical medicine.radiation exposure, including low-dose exposures.
Increasingly detailed genome maps have aidedFurthermore, damage and risks caused by exposure
researchers seeking genes associated with dozens ofto mutagenic chemicals and cancer-causing toxins also
genetic conditions, including myotonic dystrophy,can be assessed. Consequently, the likelihood of
fragile X syndrome, neurofibromatosis types 1 and 2,heritable mutations can be reduced.
inherited colon cancer, Alzheimer's disease, and familial